Metoclopramide

Generic Name
Metoclopramide
Brand Names
Gimoti, Reglan
Drug Type
Small Molecule
Chemical Formula
C14H22ClN3O2
CAS Number
364-62-5
Unique Ingredient Identifier
L4YEB44I46
Background

Diabetic gastroparesis is a condition that causes frequent nausea and vomiting, which has a negative impact on quality of life and poses a significant burden on the healthcare system. Metoclopramide is a dopamine antagonist used to treat nausea and vomiting that may be associated with diabetic gastroparesis in addition to gastroesophageal reflux disease (GER...

Indication

Metoclopramide in the oral tablet form is used for symptomatic treatment of both acute and recurrent diabetic gastroparesis, in addition to the treatment of gastroesophageal reflux disease (GERD) in patients who have failed to respond to traditional therapy. A nasal spray formulation is also indicated to treat adults with acute, recurrent diabetic gastropare...

Associated Conditions
Chemotherapy-Induced Nausea and Vomiting, Diabetic Gastroparesis, Dyspepsia, Flatulence, Gastroesophageal Reflux, Gastroparesis, Hiccups, Hyperacidity, Migraine, Nausea and vomiting, Post Operative Nausea and Vomiting (PONV), Radiation-Induced Nausea and Vomiting, Acute, recurrent Diabetic Gastroparesis, Gastric bezoar
Associated Therapies
Facilitation of small bowel intubation therapy, Gastric emptying for radiologic procedures

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

First Posted Date
2015-06-25
Last Posted Date
2017-03-07
Lead Sponsor
Medtronic - MITG
Target Recruit Count
122
Registration Number
NCT02481219
Locations
🇺🇸

Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States

🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

🇺🇸

Pinnacle Research Group, LLC, Anniston, Alabama, United States

and more 3 locations

PEP uP Protocol in Surgical Patients

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2015-06-02
Last Posted Date
2020-10-27
Lead Sponsor
Clinical Evaluation Research Unit at Kingston General Hospital
Target Recruit Count
36
Registration Number
NCT02459275
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Jamaica Hospital Medical Center, Jamaica, New York, United States

🇺🇸

Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States

and more 1 locations

Anesthetics in Rhytidoplasty - A Comparison Study

First Posted Date
2015-04-07
Last Posted Date
2015-04-07
Lead Sponsor
Mercy Facial Plastic Surgery Center
Target Recruit Count
30
Registration Number
NCT02410460
Locations
🇺🇸

Mercy Facial Plastic Surgery Center, Springfield, Missouri, United States

A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2014-11-20
Last Posted Date
2018-04-02
Lead Sponsor
St. Louis University
Target Recruit Count
70
Registration Number
NCT02295280
Locations
🇺🇸

Saint Louis University, Saint Louis, Missouri, United States

Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2014-10-13
Last Posted Date
2022-04-11
Lead Sponsor
Mount Sinai Hospital, Canada
Registration Number
NCT02262923
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo

First Posted Date
2014-10-01
Last Posted Date
2014-10-01
Lead Sponsor
Pamukkale University
Target Recruit Count
200
Registration Number
NCT02253524

Metoclopramide as Treatment of Clozapine-induced Hypersalivation

First Posted Date
2014-08-21
Last Posted Date
2014-08-21
Lead Sponsor
Beersheva Mental Health Center
Target Recruit Count
61
Registration Number
NCT02222220
Locations
🇮🇱

Be'er Sheva Mental Health Center,, Be'er Sheva, Israel

Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-06-13
Last Posted Date
2023-02-14
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
31
Registration Number
NCT02163434
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

🇺🇸

University at Buffalo, Buffalo, New York, United States

MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy

First Posted Date
2014-05-12
Last Posted Date
2020-03-31
Lead Sponsor
Amsterdam UMC, location VUmc
Target Recruit Count
249
Registration Number
NCT02135510
Locations
🇳🇱

Tergooiziekenhuizen, Hilversum, Noord Holland, Netherlands

🇳🇱

Rijnstate, Arnhem, Netherlands

🇳🇱

Medisch Centrum Alkmaar, Alkmaar, Noord-Holland, Netherlands

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath